Literature DB >> 18725315

Dendritic cells from C57BL/6 mice undergo activation and induce Th1-effector cell responses against Campylobacter jejuni.

Vijay A K Rathinam1, Kathleen A Hoag, Linda S Mansfield.   

Abstract

Food-borne Campylobacter jejuni (Cj) is an important cause of enteritis. We showed that C57BL/6 and congenic interleukin (IL)-10(-/-) mice serve as models of Cj colonization and enteritis, respectively. Thus, C57BL/6 mice are resistant to Cj induced disease. Because dendritic cells (DCs) are central to regulating adaptive immune responses, we investigated the interaction of Cj with murine bone marrow-derived DCs (BM-DCs) to assess bacterial killing, DC activation, and the ability of Cj-infected BM-DCs to stimulate Campylobacter-specific T cell responses in vitro. BM-DCs challenged with Cj efficiently internalized and killed Cj 11168 and significantly upregulated surface MHC-II, CD40, CD80 and CD86 demonstrating a mature phenotype. Infected BM-DCs secreted significant amounts of tumor necrosis factor-alpha (TNF-alpha), IL-6 and IL-12p70. Formalin-killed Cj also induced maturation of BM-DCs with similar cytokine production but at a significantly lower magnitude than live bacteria. Maximal activation of murine BM-DCs required internalization of Cj; attachment alone was not sufficient to elicit significant responses. Also, various strains of Cj elicited different magnitudes of cytokine production from BM-DCs. Finally, in a coculture system, Cj-infected BM-DCs induced high level interferon-gamma (INF-gamma) production from CD4+T cells indicating Th1 polarization. Thus, DCs from resistant C57BL/6 mice initiate T cell responses against Cj.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18725315      PMCID: PMC4122427          DOI: 10.1016/j.micinf.2008.07.030

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  30 in total

1.  Lipopolysaccharide internalization activates endotoxin-dependent signal transduction in cardiomyocytes.

Authors:  D B Cowan; S Noria; C Stamm; L M Garcia; D N Poutias; P J del Nido; F X McGowan
Journal:  Circ Res       Date:  2001-03-16       Impact factor: 17.367

2.  Two distinct mechanisms for induction of dendritic cell apoptosis in response to intact Streptococcus pneumoniae.

Authors:  Jesus Colino; Clifford M Snapper
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

3.  Comparative genome analysis of Campylobacter jejuni using whole genome DNA microarrays.

Authors:  B M Pearson; C Pin; J Wright; K I'Anson; T Humphrey; J M Wells
Journal:  FEBS Lett       Date:  2003-11-06       Impact factor: 4.124

Review 4.  Pathophysiology of Campylobacter jejuni infections of humans.

Authors:  T M Wassenaar; M J Blaser
Journal:  Microbes Infect       Date:  1999-10       Impact factor: 2.700

5.  Induction of proinflammatory responses in the human monocytic cell line THP-1 by Campylobacter jejuni.

Authors:  Michael A Jones; Sabine Tötemeyer; Duncan J Maskell; Clare E Bryant; Paul A Barrow
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

6.  Differential uptake and killing potential of Campylobacter jejuni by human peripheral monocytes/macrophages.

Authors:  T M Wassenaar; M Engelskirchen; S Park; A Lastovica
Journal:  Med Microbiol Immunol       Date:  1997-10       Impact factor: 3.402

7.  Campylobacter jejuni enteritis.

Authors:  S Baqar; B Rice; L Lee; A L Bourgeois; A N El Din; D R Tribble; G P Heresi; A S Mourad; J R Murphy
Journal:  Clin Infect Dis       Date:  2001-08-21       Impact factor: 9.079

8.  Interleukin-21 inhibits dendritic cell activation and maturation.

Authors:  Katja Brandt; Silvia Bulfone-Paus; Donald C Foster; René Rückert
Journal:  Blood       Date:  2003-07-31       Impact factor: 22.113

9.  Human dendritic cell activation by Neisseria meningitidis: phagocytosis depends on expression of lipooligosaccharide (LOS) by the bacteria and is required for optimal cytokine production.

Authors:  Heli Uronen-Hansson; Liana Steeghs; Jennifer Allen; Garth L J Dixon; Mohamed Osman; Peter van der Ley; Simon Y C Wong; Robin Callard; Nigel Klein
Journal:  Cell Microbiol       Date:  2004-07       Impact factor: 3.715

10.  Gastroenteritis in NF-kappaB-deficient mice is produced with wild-type Camplyobacter jejuni but not with C. jejuni lacking cytolethal distending toxin despite persistent colonization with both strains.

Authors:  James G Fox; Arlin B Rogers; Mark T Whary; Zhongming Ge; Nancy S Taylor; Sandy Xu; Bruce H Horwitz; Susan E Erdman
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

View more
  21 in total

1.  Campylobacter jejuni induces extra-intestinal immune responses via Toll-like-receptor-4 signaling in conventional IL-10 deficient mice with chronic colitis.

Authors:  B Otto; L-M Haag; A Fischer; R Plickert; A A Kühl; U B Göbel; M M Heimesaat; S Bereswill
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

Review 2.  Campylobacter jejuni and associated immune mechanisms: short-term effects and long-term implications for infants in low-income countries.

Authors:  Amanda E Schnee; William A Petri
Journal:  Curr Opin Infect Dis       Date:  2017-06       Impact factor: 4.915

3.  Virulence genes and cytokine profile in systemic murine Campylobacter coli infection.

Authors:  Anja Klančnik; Maja Šikić Pogačar; Peter Raspor; Maja Abram; Sonja Smole Možina; Darinka Vučković
Journal:  Virulence       Date:  2015-06-03       Impact factor: 5.882

4.  TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria.

Authors:  Vijay A K Rathinam; Sivapriya Kailasan Vanaja; Lisa Waggoner; Anna Sokolovska; Christine Becker; Lynda M Stuart; John M Leong; Katherine A Fitzgerald
Journal:  Cell       Date:  2012-07-19       Impact factor: 41.582

5.  Caspase-8 modulates dectin-1 and complement receptor 3-driven IL-1β production in response to β-glucans and the fungal pathogen, Candida albicans.

Authors:  Neal Silverman; Katherine A Fitzgerald; Sandhya Ganesan; Vijay A K Rathinam; Lukas Bossaller; Kelly Army; William J Kaiser; Edward S Mocarski; Christopher P Dillon; Douglas R Green; Tanya N Mayadas; Stuart M Levitz; Amy G Hise
Journal:  J Immunol       Date:  2014-07-25       Impact factor: 5.422

6.  Aim2 deficiency stimulates the expression of IFN-inducible Ifi202, a lupus susceptibility murine gene within the Nba2 autoimmune susceptibility locus.

Authors:  Ravichandran Panchanathan; Xin Duan; Hui Shen; Vijay A K Rathinam; Loren D Erickson; Katherine A Fitzgerald; Divaker Choubey
Journal:  J Immunol       Date:  2010-11-05       Impact factor: 5.422

Review 7.  How a sugary bug gets through the day: recent developments in understanding fundamental processes impacting Campylobacter jejuni pathogenesis.

Authors:  Christine M Szymanski; Erin C Gaynor
Journal:  Gut Microbes       Date:  2012-03-01

8.  Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans.

Authors:  David R Tribble; Shahida Baqar; Daniel A Scott; Michael L Oplinger; Fernando Trespalacios; David Rollins; Richard I Walker; John D Clements; Steven Walz; Paul Gibbs; Edward F Burg; Anthony P Moran; Lisa Applebee; A Louis Bourgeois
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

9.  The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses.

Authors:  Vijay A K Rathinam; Zhaozhao Jiang; Stephen N Waggoner; Shruti Sharma; Leah E Cole; Lisa Waggoner; Sivapriya Kailasan Vanaja; Brian G Monks; Sandhya Ganesan; Eicke Latz; Veit Hornung; Stefanie N Vogel; Eva Szomolanyi-Tsuda; Katherine A Fitzgerald
Journal:  Nat Immunol       Date:  2010-03-28       Impact factor: 25.606

10.  Campylobacter jejuni outer membrane vesicles play an important role in bacterial interactions with human intestinal epithelial cells.

Authors:  Abdi Elmi; Eleanor Watson; Pamela Sandu; Ozan Gundogdu; Dominic C Mills; Neil F Inglis; Erin Manson; Lisa Imrie; Mona Bajaj-Elliott; Brendan W Wren; David G E Smith; Nick Dorrell
Journal:  Infect Immun       Date:  2012-09-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.